McEwan P, Darlington O, McMurray JJV, Jhund PS, et al. Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF. Eur J Heart Fail 2020 Aug 4. doi: 10.1002/ejhf.1978.
PMID: 32749733